Exelon reported third-quarter 2026 GAAP net income of $0.70 per share, down from $0.86 a year earlier. Adjusted operating earnings, a non-GAAP measure, were $0.87 per share, up from $0.86.
The two figures should not be combined or treated as interchangeable. Exelon’s adjusted measure removes specified after-tax items included in reported GAAP net income; its filing contains the reconciliation.
Reported result and adjusted measure
Amounts are US dollars. The table is based on Exelon’s SEC-filed Exhibit 99.1, checked 1 November 2026 at 05:01:19 UTC.
| Measure | Q3 2026 | Q3 2025 | Official evidence |
|---|---|---|---|
| GAAP net income per share | $0.70 | $0.86 | Third-quarter results |
| Adjusted operating earnings per share | $0.87 | $0.86 | Third-quarter results and reconciliation |
| Full-year 2026 adjusted operating EPS outlook | $2.85–$2.91 | Not a completed-period result | Earnings release highlights |
Outlook is a forecast
Exelon narrowed its full-year 2026 adjusted operating earnings guidance range to $2.85–$2.91 per share. This is management’s forward-looking adjusted outlook, not reported full-year GAAP earnings. The release also contains forward-looking statements and associated risk language; actual future results may differ.
Dividend is declared, not paid
On 30 October, Exelon’s board declared a regular quarterly common-stock dividend of $0.42 per share. The release says it is scheduled to be payable on 15 December 2026 to shareholders of record at the close of business on 4 December 2026. It is a declared dividend with a stated future payment date; this report does not establish that payment has occurred or make any statement about eligibility beyond the disclosed record-date condition.
What to watch
Future reported GAAP results and the filed reconciliation can show how the adjusted measure compares with reported earnings over time. This release does not establish an analyst-expectations result, a yield calculation or a market outcome.
Primary source record
Exelon Exhibit 99.1 filed with the SEC — issuer: Exelon Corporation; observed 2026-11-01T05:01:19Z. AI-assisted primary-document comparison; not independent human editorial approval. Tatai is the publisher-designated author. This is financial information, not personalised investment advice.
Cross-check: Exelon Q3 2026 Form 10-Q filed with the SEC was reviewed alongside the release. Both are official primary records; the filing provides the detailed quarterly record, while the release supplies the current-period summary and disclosed adjusted measures or outlook where applicable.
Recorded source observation: . This is a source-check timestamp, not a market quote or a new article update.